Please use this identifier to cite or link to this item: http://doi.org/10.25358/openscience-8725
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKeller, Karsten-
dc.contributor.authorGeyer, Martin-
dc.contributor.authorHobohm, Lukas-
dc.contributor.authorTamm, Alexander R.-
dc.contributor.authorKreidel, Felix-
dc.contributor.authorRuf, Tobias F.-
dc.contributor.authorHell, Michaela-
dc.contributor.authorSchmitt, Volker H.-
dc.contributor.authorBachmann, Kevin-
dc.contributor.authorBorn, Sonja-
dc.contributor.authorSchulz, Eberhard-
dc.contributor.authorMünzel, Thomas-
dc.contributor.authorBardeleben, Ralph S. von-
dc.date.accessioned2023-02-03T10:58:02Z-
dc.date.available2023-02-03T10:58:02Z-
dc.date.issued2022-
dc.identifier.urihttps://openscience.ub.uni-mainz.de/handle/20.500.12030/8741-
dc.description.abstractBackground The number of MitraClip® implantations increased significantly in recent years. Data regarding the impact of weight class on survival are sparse. Hypothesis We hypothesized that weight class influences survival of patients treated with MitraClip® implantation. Methods We investigated in-hospital, 1-year, 3-year, and long-term survival of patients successfully treated with isolated MitraClip® implantation for mitral valve regurgitation (MR) (June 2010–March 2018). Patients were categorized by weight classes, and the impact of weight classes on survival was analyzed. Results Of 617 patients (aged 79.2 years; 47.3% females) treated with MitraClip® implantation (June 2010–March 2018), 12 patients were underweight (2.2%), 220 normal weight (40.1%), 237 overweight (43.2%), and 64 obesity class I (11.7%), 12 class II (2.2%), and 4 class III (0.7%). Preprocedural Logistic EuroScore (21.1 points [IQR 14.0–37.1]; 26.0 [18.5–38.5]; 26.0 [18.4–39.9]; 24.8 [16.8–33.8]; 33.0 [25.9–49.2]; 31.6 [13.1–47.6]; p = .291) was comparable between groups. Weight class had no impact on in-hospital death (0.0%; 4.1%; 1.5%; 0.0%; 7.7%; 0.0%; p = .189), 1-year survival (75.0%; 72.0%; 76.9%; 75.0%; 75.0%; 33.3%; p = .542), and 3-year survival (40.0%; 36.8%; 38.2%; 48.6%; 20.0%; 33.3%; p = .661). Compared to normal weight, underweight (hazard ratio [HR]: 1.35 [95% confidence interval [CI]: 0.65–2.79], p = .419), obesity-class I (HR: 0.93 [95% CI: 0.65–1.34], p = .705), class II (HR: 0.39 [95% CI: 0.12–1.24], p = .112), and class III (HR: 1.28 [95% CI: 0.32–5.21], p = .726) did not affect long-term survival. In contrast, overweight was associated with better survival (HR: 1.32 [95% CI: 1.04–1.68], p = .023). Conclusion Overweight affected the long-term survival of patients undergoing MitraClip® implantation beneficially compared to normal weight.en_GB
dc.description.sponsorshipGefördert durch die Deutsche Forschungsgemeinschaft (DFG) - Projektnummer 491381577de
dc.language.isoengde
dc.rightsCC BY*
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subject.ddc610 Medizinde_DE
dc.subject.ddc610 Medical sciencesen_GB
dc.titleSurvival benefit of overweight patients undergoing MitraClip® procedure in comparison to normal-weight patientsen_GB
dc.typeZeitschriftenaufsatzde
dc.identifier.doihttp://doi.org/10.25358/openscience-8725-
jgu.type.contenttypeScientific articlede
jgu.type.dinitypearticleen_GB
jgu.type.versionPublished versionde
jgu.type.resourceTextde
jgu.organisation.departmentFB 04 Medizinde
jgu.organisation.number2700-
jgu.organisation.nameJohannes Gutenberg-Universität Mainz-
jgu.rights.accessrightsopenAccess-
jgu.journal.titleClinical cardiologyde
jgu.journal.volume45de
jgu.journal.issue12de
jgu.pages.start1236de
jgu.pages.end1245de
jgu.publisher.year2022-
jgu.publisher.nameWileyde
jgu.publisher.placeWeinheim u.a.de
jgu.publisher.issn1932-8737de
jgu.organisation.placeMainz-
jgu.subject.ddccode610de
jgu.publisher.doi10.1002/clc.23897de
jgu.organisation.rorhttps://ror.org/023b0x485-
jgu.subject.dfgLebenswissenschaftende
Appears in collections:DFG-491381577-G

Files in This Item:
  File Description SizeFormat
Thumbnail
survival_benefit_of_overweigh-20230131124800200.pdf1.4 MBAdobe PDFView/Open